1. Home
  2. ZLAB vs VTLE Comparison

ZLAB vs VTLE Comparison

Compare ZLAB & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • VTLE
  • Stock Information
  • Founded
  • ZLAB 2013
  • VTLE 2006
  • Country
  • ZLAB China
  • VTLE United States
  • Employees
  • ZLAB N/A
  • VTLE 405
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • VTLE
  • Sector
  • ZLAB Health Care
  • VTLE
  • Exchange
  • ZLAB Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • VTLE 639.3M
  • IPO Year
  • ZLAB 2017
  • VTLE 2011
  • Fundamental
  • Price
  • ZLAB $32.89
  • VTLE $16.42
  • Analyst Decision
  • ZLAB Buy
  • VTLE Hold
  • Analyst Count
  • ZLAB 6
  • VTLE 11
  • Target Price
  • ZLAB $57.22
  • VTLE $25.22
  • AVG Volume (30 Days)
  • ZLAB 819.9K
  • VTLE 2.0M
  • Earning Date
  • ZLAB 11-11-2025
  • VTLE 11-05-2025
  • Dividend Yield
  • ZLAB N/A
  • VTLE N/A
  • EPS Growth
  • ZLAB N/A
  • VTLE N/A
  • EPS
  • ZLAB N/A
  • VTLE N/A
  • Revenue
  • ZLAB $427,799,000.00
  • VTLE $1,935,411,000.00
  • Revenue This Year
  • ZLAB $42.62
  • VTLE $1.16
  • Revenue Next Year
  • ZLAB $55.12
  • VTLE N/A
  • P/E Ratio
  • ZLAB N/A
  • VTLE N/A
  • Revenue Growth
  • ZLAB 32.56
  • VTLE 5.26
  • 52 Week Low
  • ZLAB $20.17
  • VTLE $12.30
  • 52 Week High
  • ZLAB $44.34
  • VTLE $36.72
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.59
  • VTLE 49.25
  • Support Level
  • ZLAB $31.68
  • VTLE $15.93
  • Resistance Level
  • ZLAB $33.06
  • VTLE $17.11
  • Average True Range (ATR)
  • ZLAB 1.33
  • VTLE 0.78
  • MACD
  • ZLAB 0.27
  • VTLE -0.03
  • Stochastic Oscillator
  • ZLAB 85.08
  • VTLE 28.76

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: